Results 21 - 30 of 34 : Previous 1 2 3 4 Next
A drug application a week is all we ask.
Top picks from this fund family giant.
6 Foreign Values With Star Power
What can CAPS tell us about some alluring investments beyond our borders?
Onyx's partner files a marketing application to expand the use of its lead drug.
Where is pharmaceutical company Onyx headed?
Johnson & Johnson's Pretty Pipeline
JNJ highlights its pharmaceutical segment.
Nexavar study results prove to be especially promising for this biopharmaceutical company.
Most higher-performing funds share one trait in common.
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
The private equity firm's buyout binge seems set to continue.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK